Problem statement for the industry
Pharma companies are pursuing the ultimate moonshot goal of changing the way medicines are developed so the right treatment can be delivered to the right patient at the right time. Thus, enabling the delivery of highly personalized healthcare, which effects the Pharma, Life Science and Healthcare verticals.
“You can’t over-communicate.”
It’s a saying many physicians and IT leaders are familiar with and, for many years, it held true. But in today’s world, where data is being collected from all types of devices, that’s no longer the case. “The reality is, you absolutely can over-communicate, and drive people crazy so that they don’t see anything,” said Becky Fox, CNIO at Atrium Health, during a recent panel discussion.
At Monument Health, a large, integrated health system serving 14 rural and urban communities across western South Dakota and eastern Wyoming, the ability to close gaps in care depends on the availability of data at the point of care.
What is the key to driving digital innovation with data analytics—and where should healthcare leaders begin?
According to a recent Accenture analysis, two out of three life sciences organizations struggle to achieve optimal return from their investments in cloud computing. This is unfortunate, considering that the cloud is clearly emerging as a game changer in pharma, biotech, medtech and other companies in this space. In pharma alone, the cloud computing market is expected to reach $12.1 billion in 2022, up from $4.7 billion in 2017.
Through and beyond the global pandemic, ensuring regulatory compliance and data security is critical for leaders across the accelerating healthcare and life sciences industries. Organizations dealing with a patient’s personal health information must meet the required regulations for protecting and securing the information to avoid data breaches. Working with a HITRUST certified vendor can assure partners and patients that their data is maintained with the highest level of security.
Roche, the pharma giant discusses their experiences on leveraging neutral zone for data collaboration to accelerate drug discovery and personalized medicine.
It is estimated that the global life sciences analytics market is projected to reach USD 42 billion by 2025 (MarketsandMarkets). Hence data analytics is becoming increasingly important among life sciences organizations.
